This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Favism(Favism)(Favism)

Classification codes: ICD-10 D55.0 / V163 | Synonyms: G6PD deficiency fava bean reaction, Favism G6PD, Fava bean hemolysis, G6PD deficiency (favism type) | Adult onset: Not low (a first episode can occur in adults eating fava beans for the first time, even if previously asymptomatic)

Contents


1. History

Fava beans and ancient Mediterranean civilizations

The name favism itself derives from the Italian word fava, meaning fava bean. The fava bean (Vicia faba, broad bean) is a plant that has been cultivated and eaten for thousands of years around the Mediterranean, in the Middle East, Egypt, Greece and elsewhere, and is an indispensable ingredient in the traditional diets of these regions. The record that Pythagoras (c. 570–495 BC) forbade his disciples from eating fava beans has been widely known since antiquity, and various interpretations have been offered for the background of this taboo. Some scholars argue that Pythagoras may have empirically recognized the severe jaundice and anemia occurring in certain people after eating fava beans and forbidden them for that reason, which from a modern medical perspective is interpreted as suggesting favism due to G6PD deficiency.

Clinical records in Italy and establishment of the name

In the late 19th and early 20th centuries, cases of acute jaundice and anemia after eating fava beans began to be systematically documented in Sardinia and southern Italy. In 1894, Fermi and Martinetti and other Italian physicians clinically described the association between fava beans and acute jaundice and anemia, and it was observed that this phenomenon occurred particularly often in certain Mediterranean regions, including Sardinia. The phenomenon became established in the medical literature in the early 20th century under the name 'favism.'

Link with G6PD deficiency

After Paul Carson and colleagues discovered red cell G6PD deficiency in 1956, the relationship between favism and G6PD deficiency began to be elucidated. Through studies by Zinkham and Lenney in 1958, followed by Beutler and others in the 1960s, it was confirmed that favism occurs only in patients with G6PD deficiency and that specific components of fava beans (vicine, convicine) induce oxidative stress. However, not everyone with G6PD deficiency develops favism, and other contributing factors (e.g., concomitant infection, severity of G6PD deficiency) influence the occurrence of episodes.


2. Causes

Active components of fava beans: vicine and convicine

The direct cause of favism is the pyrimidine glycosides vicine and convicine contained in fava beans (Vicia faba). These two components are hydrolyzed in the small intestine by intestinal bacteria or enzymes to produce divicine and isouramil, respectively. Divicine and isouramil produce reactive oxygen species (ROS) through autoxidation, inducing strong oxidative stress. In normal red cells this oxidative stress is offset by glutathione (GSH), but in red cells lacking GSH due to G6PD deficiency it leads to hemoglobin oxidation, Heinz body formation and ultimately hemolysis.

Inhalational triggering by pollen exposure

Favism can occur not only from directly eating fava beans but also from exposure to fava bean pollen. Hemolytic episodes via the inhalational route have been reported in G6PD-deficient patients who worked near fava bean fields during the flowering season (mainly spring to early summer) or were continuously exposed to the pollen. This suggests that vicine and convicine or their metabolites can be absorbed through the respiratory mucosa.

G6PD deficiency: a necessary condition for favism

Favism occurs only in patients with G6PD deficiency. People with normal G6PD activity do not develop any hemolysis even after eating the same amount of fava beans. Conversely, however, having G6PD deficiency does not mean that hemolysis necessarily occurs every time fava beans are eaten. Whether favism occurs is determined by a combination of factors, including the severity of G6PD deficiency (Class II/III or above), the amount of fava beans eaten, the maturity of the beans (raw or cooked), the cooking method and the presence of concomitant infection.


3. Genetics

G6PD variants associated with favism

Because favism is a phenotype occurring in patients with G6PD deficiency, its genetic background is variants of the G6PD gene (Xq28). Favism is particularly strongly associated with the Mediterranean type G6PD Med (Class II, Ser188Phe variant). The Mediterranean type occurs at high frequency in Sardinia, Greece, Italy, the Middle East, Iran and elsewhere, and combined with a food culture fond of fava beans, favism is prominent. Favism can also occur with the African type G6PD A- (Class III), but because the degree of enzyme deficiency is milder than Class II, symptoms tend to be less severe.

X-linked recessive inheritance and sex differences

Because the G6PD gene is located on the X chromosome, favism appears much more commonly in males. Males are hemizygous, and carrying even one variant allele results in full expression of G6PD deficiency. Female heterozygotes (carriers) show a varied spectrum of G6PD activity between normal and deficient due to the mosaic effect of X-inactivation, and some develop clinically significant favism. Severe favism has also been reported in homozygous or compound heterozygous females.

Interaction with environmental and dietary factors

The varied pattern of favism even among individuals carrying the same G6PD variant is because, besides the G6PD gene, other genetic factors (e.g., genes related to glutathione synthesis, hemoglobin genotype) and environmental factors (amount of fava beans eaten, maturity of the beans, concomitant infection) act in combination. This shows that favism is not a simple single-gene disease but a typical example of gene-environment interaction.


4. General epidemiology

Concentrated distribution in the Mediterranean and Middle East

Historically, favism has occurred most frequently around the Mediterranean (Italy, Sardinia, Greece, Spain), in the Middle East (Iran, Iraq, Egypt, Lebanon, Türkiye) and in North Africa (Tunisia, Libya, Algeria), where fava beans are a traditional ingredient, and sporadic cases are still reported today in these regions with a high prevalence of G6PD deficiency. In Sardinia, the prevalence of G6PD Med reaches about 7–12% of males, and it is the historical center of favism research.

Asia and Africa

Because fava beans are also cultivated and eaten in Southeast Asia, East Africa, Ethiopia and elsewhere, favism can occur in these regions as well when patients with G6PD deficiency are exposed to fava beans. Cases of favism are being reported in regions such as Ethiopia, where fava bean consumption is high and the prevalence of G6PD deficiency is high, and in these regions education about fava beans, along with G6PD deficiency screening, is important for public health.

Immigrant populations and worldwide occurrence

As immigrant groups from the Mediterranean and Middle East have settled in various regions around the world, cases of favism are also reported in immigrant communities that continue to eat fava beans as a traditional ingredient. In Korea, eating fava beans is not common, but caution is needed because favism may occur in patients with G6PD deficiency among immigrants from Southeast Asia or in those trying fava bean dishes.


5. Pathophysiology

Intestinal metabolism of vicine and convicine and induction of oxidative stress

After eating fava beans, vicine and convicine are hydrolyzed by β-glucosidase of small intestinal epithelial cells and intestinal bacteria to produce divicine and isouramil, respectively. Divicine and isouramil are water-soluble pyrimidine compounds that are rapidly absorbed in the intestine and reach the red cells in the blood. In the presence of oxygen, they produce reactive oxygen species (ROS) such as hydrogen peroxide (H₂O₂) and superoxide (O₂⁻) through autoxidation. These ROS should be neutralized by GSH (reduced glutathione), but in G6PD-deficient red cells the capacity to regenerate GSH is severely impaired, so oxidative damage is accelerated.

Heinz body formation and extravascular and intravascular hemolysis

The ROS generated by divicine and isouramil oxidize the globin chains of hemoglobin and membrane proteins. Oxidized hemoglobin denatures into insoluble methemoglobin aggregates that attach to the red cell membrane, appearing as Heinz bodies on crystal violet staining. Red cells containing Heinz bodies are destroyed by two routes: extravascular hemolysis, in which they are selectively removed by macrophages of the spleen and liver, and intravascular hemolysis, due to direct rupture of the red cell membrane.

Variability of occurrence: a different reaction each time, even in the same person

A clinically interesting feature of favism is that the same G6PD-deficient patient may not develop hemolysis every time fava beans are eaten. This is because the content of vicine and convicine in fava beans varies greatly with growing conditions, maturity and cooking method. Raw fava beans have higher vicine and convicine content than cooked ones. In addition, extra oxidative stress from concomitant infection, the individual's red cell G6PD activity (especially the proportion of young red cells) and whether there was a recent hemolytic episode before eating act in combination.


6. Symptoms

Time to onset after eating fava beans and initial symptoms

Symptoms of favism usually appear within a few hours to 3 days after eating fava beans. Generally, symptoms appear faster and more severely when large amounts of raw fava beans are eaten, while with small amounts of cooked fava beans onset may be later or symptoms mild. Initial symptoms include sudden fatigue and weakness, pallor, headache and dizziness, sometimes accompanied by gastrointestinal symptoms (abdominal pain, nausea, vomiting).

Jaundice and dark urine

As hemolysis progresses, jaundice (yellow discoloration of the sclera and skin) becomes evident. As red cells are destroyed in large numbers, the released hemoglobin is filtered by the kidneys, producing dark brown or black urine (hemoglobinuria). This change in urine color is often the first abnormality noticed by family members or caregivers and is an important symptom prompting an immediate visit to a medical institution.

Clinical picture of severe hemolysis

In severe favism, rapid anemia can cause marked tachycardia, hypotension, dyspnea and exhaustion. Particularly in children with severe anemia, pallor, lethargy and listlessness are prominent, and without appropriate treatment it can progress to shock. Oliguria or anuria due to acute renal tubular injury from hemoglobinuria is an early sign of renal failure and requires immediate intensive treatment.


7. Signs

Hematologic test findings

On peripheral blood smear, red cells containing Heinz bodies are observed, confirmed by crystal violet staining. Schistocytes, spherocytes and ghost cells are seen, and an increased reticulocyte count indicates the regenerative response of the bone marrow. Hemoglobin (Hb) falls sharply (in some cases to 4–5 g/dL or below), LDH and indirect bilirubin rise, and haptoglobin disappears.

Urinalysis findings

The urine appears dark brown to black, with a strongly positive urine occult blood reaction and positive urine protein. Direct urine hemoglobin detection is positive, and the degree of intravascular hemolysis can be estimated by measuring urine free hemoglobin.

Physical examination and other findings

On physical examination, jaundice of the sclera and skin, pallor and tachycardia are characteristic. The spleen may be palpable (especially when there have been recurrent hemolytic episodes), and abdominal tenderness (in the splenic area) may also appear. In pediatric patients, marked lethargy and hypotonia are observed. As renal failure progresses, edema, oliguria and elevated serum creatinine appear.


8. Screening

Screening of high-risk groups for favism

The most effective screening for favism is confirming G6PD deficiency status before eating fava beans. Routine G6PD screening is recommended in patients from regions with a high prevalence of G6PD deficiency (Mediterranean, Middle East, Africa, Southeast Asia) before prescribing antimalarials, or in patients from food cultures that eat many fava beans. In large communities, identifying deficient children early through newborn G6PD screening and providing fava bean avoidance education to families is the most effective favism prevention strategy.

Point-of-care tests and semiquantitative methods

In resource-limited medical settings, point-of-care tools such as the fluorescent spot test (FST) and rapid lateral flow immunoassay are used for G6PD deficiency screening. These methods give results on site within minutes without specialized equipment, making them useful for screening in rural areas and settings with limited medical resources. However, heterozygous females show intermediate G6PD activity and may be misclassified as normal on semiquantitative tests, so in doubtful cases confirmation by quantitative enzyme activity measurement or genetic testing is needed.

Limitations of testing during acute episodes

G6PD testing performed during an acute hemolytic episode can give false negatives. This is because older red cells with low G6PD activity are lost first through hemolysis, and reticulocytes with relatively higher G6PD activity increase. Therefore, even if acute-phase test results are near normal, when G6PD deficiency is clinically suspected, retesting during the recovery phase (4–8 weeks or more after hemolysis) is recommended.


9. Diagnosis

Clinical diagnosis: combination of fava bean exposure and acute hemolysis

The clinical diagnosis of favism begins by linking a history of eating fava beans or exposure to fava bean pollen with the clinical findings of subsequent acute hemolytic anemia. When jaundice, pallor and dark brown urine appear within a few hours to 3 days after eating fava beans in a patient from the Mediterranean, Middle East or Africa, favism should be suspected first. In particular, when this pattern appears in boys (children), favism is clinically likely.

G6PD enzyme activity measurement and genetic testing

Confirmation is made by G6PD enzyme activity measurement. Given the possibility of false negatives in the acute phase, retesting must be performed 4–8 weeks after recovery from hemolysis. G6PD deficiency associated with favism is diagnosed when activity is less than 10% of normal (Class II) or 10–60% (Class III). Identification of G6PD Med (Ser188Phe), G6PD Canton or other Class II/III variants on genetic testing supports the diagnosis.

Differential diagnosis

The main diseases to be differentiated from favism include hemolytic anemia from other causes (autoimmune hemolytic anemia, drug-induced hemolysis, hereditary spherocytosis, pyruvate kinase deficiency), acute hepatitis and DIC accompanying sepsis. Because the diagnosis of favism may be delayed when the history of fava bean exposure is not clear, it is important always to check for fava bean exposure in patients from the Mediterranean, Middle East or Africa with acute hemolysis.


10. Treatment

Immediate cessation of fava beans and supportive care

The most important first treatment of favism is to stop eating fava beans immediately and block continued exposure. In mild to moderate favism (hemoglobin >7 g/dL, stable vital signs), most cases improve spontaneously with adequate fluid supply and observation. Adequate oral fluid intake or intravenous fluids are given to prevent renal tubular injury due to hemoglobinuria and to maintain urine output.

Blood transfusion

In severe anemia (hemoglobin <7 g/dL or with clinical evidence of cardiopulmonary compromise), red blood cell transfusion is required. Transfused normal red blood cells have normal G6PD activity and therefore do not hemolyze, making them effective for correcting anemia. In children with severe anemia, appropriate transfusion is a key intervention for preventing heart failure and brain injury.

Management of acute renal failure and intensive care

When acute renal tubular injury due to hemoglobinuria occurs, measures such as intensive fluid therapy, diuretics, and urine alkalinization are carried out. Dialysis (hemodialysis or peritoneal dialysis) may be needed if the condition progresses to oliguria or anuria. Patients with severe favism should receive intensive care under intensive care unit monitoring.


11. Prognosis

Prognosis with appropriate treatment

The prognosis of favism depends largely on the speed of diagnosis and the appropriateness of treatment. In most cases, when fava bean exposure is stopped and appropriate supportive care is provided, hemoglobin recovers within a few days to 2 weeks. Mild episodes may resolve with outpatient treatment without hospitalization. Even in severe episodes, most patients recover completely with appropriate transfusion and intensive care.

Poor prognostic factors

Prognosis may be poor when treatment is delayed, when acute renal failure is present, or when transfusion is not given promptly in severe anemia (hemoglobin <5 g/dL or below). In children, especially neonates, progression to kernicterus can be rapid, so prompt treatment is important. With repeated favism episodes, splenomegaly and cholelithiasis (hemolytic gallstones) may accumulate.

Prevention of recurrence and long-term management

Once a diagnosis of G6PD deficiency is established after a favism episode, education on avoiding fava beans and other G6PD triggers follows, and recurrence can be prevented. Because recurrence is always possible if fava beans are eaten again, dietary avoidance must be maintained for life. Patients who receive adequate education after a diagnosis of G6PD deficiency can maintain a near-normal quality of life.


12. Prevention

Fava bean avoidance and dietary education

The most direct way to prevent favism in patients with G6PD deficiency is permanent avoidance of fava beans (Vicia faba) and foods containing them. Fava beans are used in foods in many forms: raw fava beans, boiled fava beans, roasted fava beans, fava bean pasta, breads and snacks containing fava bean flour, the traditional Middle Eastern dish ful medames (an Egyptian fava bean dish), and Italian fave dishes. Patients with G6PD deficiency who are exposed for the first time to cultures that consume fava beans, through travel or immigration, need particular caution. Exposure to fava bean pollen should also be avoided, so caution is required when working in fava bean-growing areas in spring.

Regional public health policy: reducing vicine content in fava beans

As a public health approach to preventing favism, research has been conducted on developing low-vicine fava bean varieties with reduced vicine and convicine content. Related research has been carried out in Italy and Sardinia, and the spread of low-vicine varieties may improve the safety of fava bean consumption for patients with G6PD deficiency, but they have not yet reached commercialization.

Medical alert systems and community education

Patients diagnosed with G6PD deficiency should inform all prescribing clinicians of their G6PD deficiency status and make a habit of checking the ingredients of medications purchased without a prescription (OTC drugs). Ideally, children of Mediterranean and Middle Eastern origin should receive early diagnosis and dietary education through newborn G6PD screening and school health education. In families that enjoy eating fava beans, access to fava beans by children with G6PD deficiency should be clearly restricted, and the whole family should be educated about the characteristics of this condition and avoidance strategies.


13. References

  1. Luzzatto L, Nwaka S. G6PD deficiency and malaria. Blood Cells Mol Dis. 2007;39(3):273-274.
  2. Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008;371(9606):64-74.
  3. Luzzatto L, Ally M, Notaro R. Glucose-6-phosphate dehydrogenase deficiency. Blood. 2020;136(11):1225-1240.
  4. Beutler E. Glucose-6-phosphate dehydrogenase deficiency and favism: a personal account. N Engl J Med. 1994;331(20):1387-1388.
  5. Arese P, Turrini F, Bussolino F. Mechanisms of favism. In: Yoshida A, Beutler E (eds). Glucose-6-Phosphate Dehydrogenase. Academic Press; 1986:451-468.
  6. Belsey MA. The epidemiology of favism. Bull World Health Organ. 1973;48(1):1-13.
  7. Mehta A, Mason PJ, Vulliamy TJ. Glucose-6-phosphate dehydrogenase deficiency. Best Pract Res Clin Haematol. 2000;13(1):21-38.
  8. Manco L, Bento C, Victor BL, et al. Favism in young Portuguese males: clinical and molecular characterization. Eur J Haematol. 2006;77(5):430-433.
  9. Walker DH, Barbour AG, Oliver JH, et al. Emerging bacterial zoonotic and vector-borne diseases. JAMA. 1996;275(6):463-469. (context reference)
  10. Ruwende C, Khoo SC, Snow RW, et al. Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature. 1995;376(6537):246-249.
  11. Luzzatto L, Seneca E. G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications. Br J Haematol. 2014;164(4):469-480.
  12. Noronha SA, Rose MJ. Favism (G6PD Deficiency). In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024.